Gianpaolo Pozzato on Advancing Hemostasis Automation Through HemoCell and Axonlab Collaboration
Gianpaolo Pozzato, EEMEA Hemostasis Product Manager, shared on LinkedIn:
”Kicked off 2026 with a focused visit to Basel, Switzerland, returning to our HemoCell installation to further optimize performance and resilience.
Why the Werfen dedicated, specialized automation matters in Hemostasis:
– Consistent, standardized workflows
– Reliable TAT even at peak load
– Strong QC, full traceability, and smart reflex testing
This trip was about aligning system capabilities with the evolving complexity of Hemostasis workloads, and translating user feedback into measurable operational gains.
Grateful to Daria Prokudina, MD for the expert on‑site support, and to our Partner Axonlab international for the excellent collaboration and hospitality.
Together we keep raising the bar for patient‑centric diagnostics.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers